Cancer Immunotherapy Market Analysis According to Renub Research global cancer immunotherapy market is entering a phase of accelerated expansion, driven by rising cancer prevalence, continuous innovation in immuno-oncology, and increasing acceptance of immune-based treatments as standard cancer care. In 2024, the market was valued at USD 105.7 billion and is projected to reach USD 254.6 billion...